HK1192237A1 - 具有噁唑並 吡啶環的羧酸衍生物 - Google Patents
具有噁唑並 吡啶環的羧酸衍生物Info
- Publication number
- HK1192237A1 HK1192237A1 HK14105589.0A HK14105589A HK1192237A1 HK 1192237 A1 HK1192237 A1 HK 1192237A1 HK 14105589 A HK14105589 A HK 14105589A HK 1192237 A1 HK1192237 A1 HK 1192237A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- oxazolo
- carboxylic acid
- acid derivatives
- pyrimidine ring
- pyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11305879 | 2011-07-07 | ||
| EP12305527 | 2012-05-11 | ||
| PCT/EP2012/063302 WO2013004828A1 (de) | 2011-07-07 | 2012-07-06 | Carbonsäurederivate mit einem oxazolo [4, 5-c] pyridinring |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1192237A1 true HK1192237A1 (zh) | 2014-08-15 |
Family
ID=46514336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK14105589.0A HK1192237A1 (zh) | 2011-07-07 | 2014-06-13 | 具有噁唑並 吡啶環的羧酸衍生物 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8735402B2 (zh) |
| EP (1) | EP2729475B8 (zh) |
| JP (1) | JP5913586B2 (zh) |
| KR (1) | KR20140061386A (zh) |
| CN (1) | CN103797015B (zh) |
| AU (1) | AU2012280208B2 (zh) |
| BR (1) | BR112014000078A2 (zh) |
| CA (1) | CA2841229C (zh) |
| DK (1) | DK2729475T3 (zh) |
| ES (1) | ES2547110T3 (zh) |
| HK (1) | HK1192237A1 (zh) |
| IL (1) | IL230313A (zh) |
| MX (1) | MX369847B (zh) |
| MY (1) | MY165099A (zh) |
| PT (1) | PT2729475E (zh) |
| RU (1) | RU2609003C2 (zh) |
| WO (1) | WO2013004828A1 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9321787B2 (en) | 2011-07-07 | 2016-04-26 | Sanofi | Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3679682A (en) * | 1970-04-23 | 1972-07-25 | Fmc Corp | CERTAIN 5H-ISOXAZOLO{8 5,4-d{9 PYRIMIDIN-4-ONES |
| US7060697B2 (en) * | 2003-05-19 | 2006-06-13 | Irm Llc | Immunosuppressant compounds and compositions |
| JP2011524864A (ja) * | 2008-05-30 | 2011-09-08 | メルク・シャープ・エンド・ドーム・コーポレイション | 新規な置換されたアザベンゾオキサゾール |
| TW201000099A (en) | 2008-06-20 | 2010-01-01 | Amgen Inc | S1P1 receptor agonists and use thereof |
| EP2318415B1 (en) | 2008-07-15 | 2013-02-20 | Sanofi | Oxazolopyrimidines as edg-1 receptor agonists |
| US8907093B2 (en) * | 2011-07-07 | 2014-12-09 | Sanofi | Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring |
-
2012
- 2012-06-25 US US13/532,305 patent/US8735402B2/en active Active
- 2012-07-06 DK DK12735503.0T patent/DK2729475T3/en active
- 2012-07-06 WO PCT/EP2012/063302 patent/WO2013004828A1/de active Application Filing
- 2012-07-06 KR KR1020147003228A patent/KR20140061386A/ko not_active Application Discontinuation
- 2012-07-06 EP EP12735503.0A patent/EP2729475B8/de active Active
- 2012-07-06 JP JP2014517831A patent/JP5913586B2/ja active Active
- 2012-07-06 PT PT127355030T patent/PT2729475E/pt unknown
- 2012-07-06 RU RU2014104233A patent/RU2609003C2/ru not_active IP Right Cessation
- 2012-07-06 BR BR112014000078A patent/BR112014000078A2/pt not_active IP Right Cessation
- 2012-07-06 AU AU2012280208A patent/AU2012280208B2/en not_active Ceased
- 2012-07-06 MY MYPI2014000020A patent/MY165099A/en unknown
- 2012-07-06 CN CN201280043168.XA patent/CN103797015B/zh active Active
- 2012-07-06 CA CA2841229A patent/CA2841229C/en not_active Expired - Fee Related
- 2012-07-06 ES ES12735503.0T patent/ES2547110T3/es active Active
- 2012-07-06 MX MX2014000033A patent/MX369847B/es active IP Right Grant
-
2014
- 2014-01-02 IL IL230313A patent/IL230313A/en not_active IP Right Cessation
- 2014-06-13 HK HK14105589.0A patent/HK1192237A1/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140061386A (ko) | 2014-05-21 |
| EP2729475B1 (de) | 2015-06-10 |
| EP2729475A1 (de) | 2014-05-14 |
| IL230313A (en) | 2016-08-31 |
| MY165099A (en) | 2018-02-28 |
| MX2014000033A (es) | 2014-02-17 |
| CN103797015B (zh) | 2015-12-09 |
| WO2013004828A1 (de) | 2013-01-10 |
| AU2012280208A1 (en) | 2014-02-06 |
| CA2841229A1 (en) | 2013-01-10 |
| JP2014518249A (ja) | 2014-07-28 |
| CA2841229C (en) | 2019-07-30 |
| AU2012280208B2 (en) | 2016-07-21 |
| MX369847B (es) | 2019-11-25 |
| CN103797015A (zh) | 2014-05-14 |
| PT2729475E (pt) | 2015-10-14 |
| RU2014104233A (ru) | 2015-08-20 |
| EP2729475B8 (de) | 2015-08-26 |
| US8735402B2 (en) | 2014-05-27 |
| RU2609003C2 (ru) | 2017-01-30 |
| DK2729475T3 (en) | 2015-09-21 |
| ES2547110T3 (es) | 2015-10-01 |
| JP5913586B2 (ja) | 2016-04-27 |
| BR112014000078A2 (pt) | 2016-10-18 |
| US20130023545A1 (en) | 2013-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20171724T1 (hr) | Imidazo[1,2-b]piridazin derivati kao inhibitori kinaze | |
| IL234485A (en) | Compounds based on imidazo [2,1 – b] pyridazine | |
| EP2751112A4 (en) | SUBSTITUTED PYRAZOLO [3,4-D] PYRIMIDINES AND USES THEREOF | |
| PH12013501402A1 (en) | Mesoionic Pyrido [1,2 -A] Pyrimidine Pesticides | |
| HK1194732A1 (zh) | 作為大麻素受體 激動劑的 三唑並 嘧啶衍生物 | |
| IL227526A0 (en) | Derivatives of 6-cyclobutyl-1,5-dihydro-pyrazolo [3,4-d] pyrimidine-4-one and their use as a9pde inhibitors | |
| AP3709A (en) | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts | |
| HK1219277A1 (zh) | 新的三唑並 嘧啶衍生物 | |
| EP2608669A4 (en) | NEW PYRAZOLO- [1,5-A-] PYRIMIDINE DERIVATIVES AS ANTI-MTOR HEMMER | |
| ZA201403441B (en) | [1,2,3]triazolo[4,5-d]pyrimidine derivatives as agonists of the cannabinoid | |
| ZA201406323B (en) | Triazolo[4,5-d]pyrimidine derivatives | |
| PL2694513T3 (pl) | Pochodne pirazolopirymidynowe | |
| IL221479A0 (en) | Triazolo [4,5-b] pyridin derivatives | |
| ZA201307511B (en) | Pyrido [2,3-b] pyrazine derivatives and their therapeutical uses | |
| HK1192240A1 (zh) | 具有噁唑並 嘧啶環的羧酸衍生物 | |
| HK1192239A1 (zh) | 具有噁唑並 吡啶環的羧酸衍生物 | |
| BR112013013282A2 (pt) | compostos de oxazolo[5,4-b]piridin-5-ila | |
| HK1192237A1 (zh) | 具有噁唑並 吡啶環的羧酸衍生物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190704 |